NanoTemper Technologies Launches DLS Capability With Prometheus Panta, Bringing High-Resolution, Domain-Specific Stability Characterization to Biologics
NanoTemper Technologies , well-known for creating tools that address challenging characterizations, today introduced Prometheus Panta, a multi-parameter stability characterization instrument. By combining DLS for particle size determination with nanoDSF for thermal unfolding and backreflection for aggregation, researchers in biologics formulation optimization, developability, or comparability assessments will find that Prometheus Panta offers superior characterization of their candidate molecules.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200924005395/en/
“Inevitably, researchers will come across candidate molecules that present challenges. Here’s where Prometheus Panta shines, offering a solution they can rely on for clear, trustworthy, and high-resolution data for colloidal and conformational stability,” said Philipp Baaske, Co-CEO of NanoTemper.
Having the right technology really matters when researchers need to detect small differences or subtleties in unfolding events. Missing these details means handing over subpar candidates to teams working downstream — a costly mistake for drug pipelines.
“For the first time, researchers are able to correlate particle sizing, thermal unfolding and aggregation results collected throughout an entire thermal ramp,” comments Charles Heffern, Product Manager at NanoTemper. “This gives them a completely new perspective about stability attributes at the domain level that they would’ve otherwise missed.” Getting clear answers to questions — Which domains have a tendency to aggregate and at what temperature does this happen? Is the increase in particle size at a certain temperature due to an unfolding event for a particular domain? — are now possible.
About NanoTemper Technologies
Our mission at NanoTemper Technologies is to enable everyone to do science that matters by always pushing the limits. We’re focused on making tools that address challenging characterizations for use in drug discovery and basic science research. Working with scientists striving to make a difference in the world gets us excited. If you’re facing challenges with affinity screening, molecular interactions, protein stability, or protein quality, let’s talk.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TOPCON-HEALTHCARE23.10.2020 07:02:03 CEST | Press release
MYAH Wins Prestigious Silmo D’Or Award
ABB23.10.2020 06:48:03 CEST | Press release
ABB: Q3 2020 Results
NY-IFF22.10.2020 22:17:06 CEST | Press release
IFF Opens New Dubai Taste Creative Center
GLOBAL-AI-SUMMIT22.10.2020 21:13:13 CEST | Press release
Saudi Arabia and International Telecommunication Union Announce MoU to Support AI for Sustainable Development Efforts
AEROGEN22.10.2020 19:59:11 CEST | Press release
Aerogen Collaborates on Development of More Than 15 Potential COVID-19 Inhaled Therapies
YIWU-FAIR22.10.2020 16:27:06 CEST | Press release
Five Highlights at the 26 th Yiwu Fair to Attract 50,000 Global Merchants
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom